Skip to main content

Day: July 18, 2025

PREMIUM CATERING (HOLDINGS) LIMITED ANNOUNCES THE NUMBER OF PRE-REVERSE SPLIT AND POST-REVERSE SPLIT CLASS A ORDINARY SHARES

SINGAPORE, July 18, 2025 (GLOBE NEWSWIRE) — Premium Catering (Holdings) Limited (“PC” or the “Company”) (Nasdaq: PC), previously announced a Share Consolidation (“Reverse Split”) of its Class A Ordinary Shares on July 11, 2025. A Reverse Stock Split of 1:9 will take place with a record date of July 21, 2025, and the Class A Ordinary Shares are expected to begin trading on a Reverse Stock Split adjusted basis on the Nasdaq Capital Market as of the open of trading on July 22, 2025, under the existing ticker symbol of “PC”. Currently, there are 18,652,750 Class A Ordinary Shares issued and outstanding. Following the Reverse Stock Split, the number of Class A Ordinary Shares issued and outstanding will be 2,072,528. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor...

Continue reading

Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval

ORLANDO, Fla., July 18, 2025 (GLOBE NEWSWIRE) — Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) (“Nutriband” or the “Company”) is today reminding shareholders of the key dates associated with its upcoming 25% Preferred stock dividend. Shareholders of record on July 25th 2025 will receive one preferred share for every four shares of common stock held. The pay date for shareholders to receive their new issuance will be August. 5th. Each preferred share will be convertible to one share of common stock following FDA approval of the Company’s AVERSA Fentanyl product. If the preferred share remains unconverted it shall be entitled to a cash dividend paid from the profits of the company on an annual basis as decided by the board of Directors. About AVERSA™ Abuse-Deterrent Transdermal Technology Nutriband’s AVERSA™ abuse-deterrent...

Continue reading

Financial Calendar for 2026 for Realkredit Danmark A/S

To Nasdaq Copenhagen A/S   Executive ManagementBernstorffsgade 40DK-1577 København Vwww.rd.dk Telephone +45 7012 5300 18 July 2025Company Announcement number 60/2025 Financial Calendar for 2026 for Realkredit Danmark A/S Realkredit Danmark A/S has set the following dates in 2026 for the publication of financial statements and the holding of the ordinary general meeting:Annual report 5 February 2026Annual general meeting 16 March 2026Company announcement for the first quarter 30 April 2026Interim report for the first half 17 July 2026Company announcement for the first nine months 29 October 2026The announcements will be available on Realkredit Danmark’s website: www.rd.dk immediately after publication.The Executive ManagementFor further inquiries, please contact Helle Meineche, tel.: +45 21 55 87 42...

Continue reading

Senti Bio Appoints Entrepreneurial Leader and Investor, Bryan Baum, to Board of Directors

SOUTH SAN FRANCISCO, Calif., July 18, 2025 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that it has appointed Bryan Baum to its Board of Directors. Mr. Baum is a serial entrepreneur and investor and is the Co-Founder and Managing Partner of K5 Global. His portfolio includes category-defining companies such as SpaceX, xAI, Anduril, Canva, Databricks, Grafana, OpenAI, and others. He has also founded and successfully exited multiple ventures. Timothy Lu, M.D., Ph.D., Senti Bio’s Co-Founder and Chief Executive Officer, commented, “We are pleased to welcome Bryan to our Board of Directors. His keen insight and successful track record have equipped...

Continue reading

Blackboxstocks Provides Stockholder Update on Acquisition of Rare Earth Company

Blackboxstocks, Inc. Stockholder Update DALLAS, July 18, 2025 (GLOBE NEWSWIRE) — Blackboxstocks Inc. (NASDAQ: BLBX) (“Blackbox”), a financial technology and social media hybrid platform, today released a stockholder update from CEO Gust Kepler: As we kick off the first month of Q3 2025, I’m excited to update our stakeholders on our developments, especially with respect to our foray into the rare earth sector with our pending acquisition of REalloys, Inc. (“REalloys”). REalloys is a U.S. based, integrated rare earth company poised to capitalize on its ability to provide high-performance magnet materials for U.S. Protected Markets. While Blackbox remains a fully operational fintech enterprise, we have taken the initiative to pursue this acquisition which we believe will greatly enhance value for our stockholders, while allowing...

Continue reading

Draganfly Announces Pricing of US$25.0 Million Registered Direct Offering

Saskatoon, SK., July 18, 2025 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), an award-winning developer of drone solutions, software, and robotics, today announced that it has entered into a securities purchase agreement with several institutional investors to purchase 4,672,895 units of the Company (the “Units”), at a price of US$5.35 per Unit, for gross proceeds of approximately US$25.0 million, before deducting placement agent discounts and offering expenses (the “Offering”). Each Unit will consist of one common share in the capital of the Company (each, a “Common Share”) and one common share purchase warrant (each, a “Warrant”). The Warrants will entitle the holder thereof to purchase one Common Share at an exercise price of CA$7.3579 (the Canadian dollar equivalent...

Continue reading

Generation Bio Announces 1-for-10 Reverse Stock Split

CAMBRIDGE, Mass., July 18, 2025 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq: GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, today announced that it will implement a 1-for-10 reverse stock split of the issued shares of the Company’s common stock (“Reverse Stock Split”), effective at 5:00 pm Eastern Time on July 21, 2025. The Reverse Stock Split was approved by the Company’s stockholders at the Company’s Annual Meeting of Stockholders held on June 4, 2025, with the final ratio subsequently determined by the Company’s Board of Directors. One of the primary goals of the Reverse Stock Split is to increase the per-share market price of the Company’s common stock to enable the Company to regain compliance with the minimum bid price requirement for continued...

Continue reading

Yoshiharu Announces 4-For-1 Stock Split

BUENA PARK, Calif., July 18, 2025 (GLOBE NEWSWIRE) — Yoshiharu Global Co. (NASDAQ: YOSH) (“Yoshiharu” or the “Company”), a restaurant operator specializing in authentic Japanese ramen & rolls, today announced that its Board of Directors authorized the stockholders approved issuance of a stock dividend to effect a 4-for-1 forward stock split (the “Forward Stock Split”) of the Company’s Class A Common Stock, par value $0.0001 per share (“Class A Common Stock”), and Class B Common Stock (“Forward Stock Split”), whereby for each share of Common Stock held, the holder will receive three additional shares in the respective class. The Forward Stock Split is intended to encourage interest in our Class A Common Stock and possibly promote greater liquidity for our stockholders. At the Effective Time of the Forward...

Continue reading

Results of the Stellantis 2025 Extraordinary General Meeting of Shareholders

Results of the Stellantis 2025 Extraordinary General Meeting of Shareholders AMSTERDAM, July 18, 2025 – Stellantis N.V. (“Stellantis”) announced today that shareholders approved the appointment of Antonio Filosa as a member of the Board of Directors and an executive director of Stellantis at the Extraordinary General Meeting (EGM).   Details of the resolution submitted to the EGM are available on the Company’s corporate website (www.stellantis.com). # # # About Stellantis Stellantis N.V. (NYSE: STLA / Euronext Milan: STLAM / Euronext Paris: STLAP) is a leading global automaker, dedicated to giving its customers the freedom to choose the way they move, embracing the latest technologies and creating value for all its stakeholders. Its unique portfolio of iconic and innovative brands includes Abarth, Alfa Romeo, Chrysler, Citroën, Dodge,...

Continue reading

Royalty Pharma Declares Third Quarter 2025 Dividend

NEW YORK, July 18, 2025 (GLOBE NEWSWIRE) — The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of 2025 of $0.22 per Class A ordinary share. The dividend will be paid on September 10, 2025, to shareholders of record at the close of business on August 15, 2025. About Royalty Pharma Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry’s...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.